NewswireToday - /newswire/ -
Orono, MN, United States, 2010/10/26 - Diabetes Sentry wins national competition held in Las Vegas, October 7th & 8th. Over 400 business plans and company pitches were submitted.
Diabetes Sentry Products, Inc., producer of the world’s first non-invasive class-3 medical device for detection of hypoglycemia, has won the 2010 Perfect Pitch Award. PerfectBusiness.com, an online network of entrepreneurs, investors and business experts working together to promote entrepreneurship, presented the award at The Perfect Pitch 2010 Entrepreneur & Investor Conference held Oct. 7th and 8th in Las Vegas, NV. The competition featured hundreds of submissions from all 50 states and eight countries. Judges included over a hundred noted entrepreneurs and venture capitalists from across the country, including Josh Stein, a Managing Director at Draper Fisher Jurvetson.
“We are thrilled about being recognized on a national level with this award – especially from such a prestigious and qualified group of judges and among such strong competitors,” said Mike Russin, Vice President of Sales & Marketing for Diabetes Sentry Products.
“While the treatment of diabetes has come a long way over the past few years, the need to protect patients from the serious risks of hypoglycemia has increased dramatically. This award substantiates the need for this type of device which is complementary to all other glucose monitors.”
The company’s product, called the Diabetes Sentry, is approved by the FDA for detecting symptoms of hypoglycemia in diabetic individuals. Hypoglycemia is a life threatening condition of insulin dependent diabetics, and no previously existing technology could accurately detect the symptoms until the Diabetes Sentry was developed. The system was originally designed to wear while sleeping, which is when most serious hypoglycemic events occur. The small device is worn like a wristwatch and produces an audible alarm when it detects either or both of the two symptoms of hypoglycemia, perspiration or drop in skin temperature. The Diabetes Sentry has received considerable praise from the 1,500+ customers who currently rely on its life saving benefits.
The company is also launching the World Hypoglycemia Prevention Foundation, a non-profit foundation that seeks to increase access to hypoglycemia prevention devices in communities across the world. As part of the launch, Diabetes Sentry has committed to donate a percentage of all Diabetes Sentry sales to the World Hypoglycemia Prevention Foundation. More information about this Foundation will be provided in subsequent press releases.
Diabetes Sentry Products is currently seeking funding and investments for both the Diabetes Sentry and the World Hypoglycemia Prevention Foundation.
About Diabetes Sentry Products Inc.
Diabetes Sentry Products, Inc. (diabetessentry.com) is the developer and manufacturer of the Diabetes Sentry, the world’s first non-invasive, class-3 medical device designed specifically for diabetics who experience, or are at risk of experiencing, hypoglycemic events. The company’s technology, which relies on non-invasive sensors, has received wide acclaim around the world. Diabetes Sentry Products is also the proud founder and lead sponsor of the World Hypoglycemia Prevention Foundation, a non-profit foundation that seeks to increase access to hypoglycemia prevention devices in communities that lack the financial resources to invest in these types of preventative devices.